Ns Scientific Immunoassay Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 10.79%
(FY 2023)
- Profit 44.15%
(FY 2023)
- Ebitda -0.08%
(FY 2023)
- Net Worth 5.76%
(FY 2023)
- Total Assets -3.24%
(FY 2023)
About Ns Scientific Immunoassay
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nandini Basu, Rupasree Dutta, and Samudra Basu serve as directors at the Company.
- CIN/LLPIN
U85195WB1992PTC056971
- Company No.
056971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ns Scientific Immunoassay?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandini Basu  | Director | 12-Nov-1992 | Current |
| Rupasree Dutta | Additional Director | 28-Nov-2022 | Current |
| Samudra Basu | Director | 20-Jun-2019 | Current |
Financial Performance of Ns Scientific Immunoassay.
Ns Scientific Immunoassay Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 10.79% increase. The company also saw a substantial improvement in profitability, with a 44.15% increase in profit. The company's net worth moved up by a moderate rise of 5.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ns Scientific Immunoassay?
Unlock access to Ns Scientific Immunoassay's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Scientific Clinical Laboratory Private LimitedActive 38 years 9 monthsNandini Basu, Rupasree Dutta and 1 more are mutual person
- Beta Clinical Laboratory Pvt LtdActive 36 years 6 months
Nandini Basu and Rupasree Dutta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ns Scientific Immunoassay?
Ns Scientific Immunoassay has a workforce of 32 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ns Scientific Immunoassay, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ns Scientific Immunoassay's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
